BK

[BK @Kuma29B]

@hotirishmonkey I’m excited to see the results from the Porter trial and hopefully @IncResilience can help manufacture the drugs one day.

[BK @Kuma29B]

@CT_Bergstrom Baby rose buds are nice too.

[Dana-Farber News @DanaFarberNews]

#Glioblastoma study shows combination immunotherapy is safe and early data on effectiveness is encouraging. Dana-Farber's David Reardon, MD, details more at #ASCO22 about the combination of a potent vaccine platform with immune checkpoint blockade
➡️ https://t.co/Z5d9unja8l

[BK @Kuma29B]

@jmcrookston

[INOVIO Pharmaceuticals @InovioPharma]

INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO Annual Meeting 2022.
Read more here: https://t.co/XduNJh6bIZ

[BK @Kuma29B]

@NIHDirector @NIAIDNews I’d like to see how this study compares with the DNA plasmid vaccine with electroporation for VEEV. https://t.co/cP33xqrQIj

[BK @Kuma29B]

@lunarstudio @VirusesImmunity I too have a plant addiction and no space. This is the first year I had to grudgingly sacrifice and pull out a couple of my hybrid tea roses to make room for David Austin roses that I wanted to try. Like you said I find myself leaning more toward peony looking roses.

[BK @Kuma29B]

I’m glad to see this published and available to the public. Also looking forward to the results for Solidarity Trial Vaccines.

[Soumya Swaminathan @doctorsoumya]

Final results of the first phase of #Solidarity trial published. Thanks to the steering committee & hundreds of doctors worldwide who contributed to this collaboration. The 2nd phase is still recruiting. @jarottingen @ProfAbdoolKarim @ProfIAbubakar @WHO https://t.co/eufqgKsFB1

[BK @Kuma29B]

30:20 minute mark Dr. Carlos Alvarez Moreno @AlvarezMorenoC principal investigator of solidarity trials of Colombia didn’t specifically mention Inovio but good to hear that clinical trials are progressing and strengthening while working with Philippines and Mali.

[World Health Organization (WHO) @WHO]

LIVE: media briefing on #COVID19, #Ukraine and other global health issues with @DrTedros https://t.co/fftj4vhADH

[BK @Kuma29B]

@bornwithnolegs @juli_bg_bs Are they still using KF94? I tried it out with some other people and found it doesn’t fit perfectly well and has noticeable small gaps. I wonder if there is a community or country that uses N95 masks (great fit for me) and what results they have.

[BK @Kuma29B]

@InovioPharma @IPVSociety Looking forward to the efficacy and safety data for VXG-3100 from REVEAL2 later this year!

[BK @Kuma29B]

@KyivIndependent If it was intentional and radiation spreads then I don’t see it being any different than a nuclear war.

[BK @Kuma29B]

Around the 48 minute mark watch Dr. Rabindra from WHO talking about the solidarity trials in the Philippines and then skip over to around the 1 hour and 28 minute mark to hear the panelists answer questions about the trials.
https://t.co/NUaM91yzqe

[BK @Kuma29B]

@NIHDirector Merry Christmas Dr. Collins!

[BK @Kuma29B]

@HelenBranswell “Vaccines that cause fewer side effects may be needed if public health authorities want to persuade people to get regular or even sporadic boosters.”

I hope to soon see a safer vaccine like plasmid DNA vaccines get approved due to the almost pristine side effect profile.

[BK @Kuma29B]

@Anony05690448 @InovioPharma 🙏

[BK @Kuma29B]

I am excited to see this evidence soon! @InovioPharma

Inicia en Veracruz estudio en fase 3 de la vacuna Inovio https://t.co/Y2xmLlZ7em

[BK @Kuma29B]

https://t.co/DZyLaKNxmZ